Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2026 Filed Feb 27, 2026 21:01 UTC |
Kelly Timothy PChief Technology Officer
|
SaleCommon Stock | 6,228 | $1.93 | $12,020.04 |
DisclosureSEC source: 0001754067-26-000004 · wk-form4_1772226070.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,125 Read SEC document |
| February 24, 2026 Filed Feb 24, 2026 20:53 UTC |
Albertson Tina M.Chief Medical Officer
|
SaleCommon Stock | 1,066 | $1.96 | $2,089.36 |
DisclosureSEC source: 0001917391-26-000002 · wk-form4_1771984424.xml · nonDerivative · entry 2 Albertson Tina M. · CIK 0001917391 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,523 F2 · kind: Reflects the number of shares of common stock that were sold in a "sell-to-cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted by the reporting person on August 12, 2024. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F2 · shares: Reflects the number of shares of common stock that were sold in a "sell-to-cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted by the reporting person on August 12, 2024. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. Read SEC document |
| February 24, 2026 Filed Feb 24, 2026 20:54 UTC |
MCCLUNG BARBARA GChief Legal Officer
|
SaleCommon Stock | 6,938 | $1.96 | $13,598.48 |
DisclosureSEC source: 0001231321-26-000002 · wk-form4_1771984473.xml · nonDerivative · entry 2 MCCLUNG BARBARA G · CIK 0001231321 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 481,564 F2 · kind: Reflects the number of shares of common stock that were sold in a "sell-to-cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F2 · shares: Reflects the number of shares of common stock that were sold in a "sell-to-cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 01:54 UTC |
Kelly Timothy PChief Technology Officer
|
SaleCommon Stock | 3,147 | $1.96 | $6,168.12 |
DisclosureSEC source: 0001754067-26-000002 · wk-form4_1771984478.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,353 F2 · kind: Reflects the number of shares of common stock that were sold pursuant to the Issuer's mandatory sell-to-cover policy for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. F2 · shares: Reflects the number of shares of common stock that were sold pursuant to the Issuer's mandatory sell-to-cover policy for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 01:54 UTC |
Khan Ruhi AhmadChief Business Officer
|
SaleCommon Stock | 6,938 | $1.96 | $13,598.48 |
DisclosureSEC source: 0001891113-26-000002 · wk-form4_1771984441.xml · nonDerivative · entry 2 Khan Ruhi Ahmad · CIK 0001891113 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,998 F2 · kind: Reflects the number of shares of common stock that were sold in a "sell-to-cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F2 · shares: Reflects the number of shares of common stock that were sold in a "sell-to-cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 17:28 UTC |
Sacks NatalieDirector
|
GrantOption to purchase Common Stock · Derivative | 45,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001683811-26-000002 · wk-form4_1771626484.xml · derivative · entry 1 Sacks Natalie · CIK 0001683811 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 17:28 UTC |
Zheng RanDirector
|
GrantOption to purchase Common Stock · Derivative | 45,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001885914-26-000002 · wk-form4_1771626495.xml · derivative · entry 1 Zheng Ran · CIK 0001885914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 17:26 UTC |
Haurwitz Rachel E.Director · President and CEO
|
GrantOption to purchase Common Stock · Derivative | 682,500 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001670579-26-000002 · wk-form4_1771626383.xml · derivative · entry 3 Haurwitz Rachel E. · CIK 0001670579 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682,500 Underlying: Common Stock · 682,500 shares Expires 2036-02-19 F3 · derivative.exercise_date: 1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 17:26 UTC |
Haurwitz Rachel E.Director · President and CEO
|
GrantCommon Stock | 151,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001670579-26-000002 · wk-form4_1771626383.xml · nonDerivative · entry 1 Haurwitz Rachel E. · CIK 0001670579 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,150 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:27 UTC |
Braunstein ScottDirector
|
GrantOption to purchase Common Stock · Derivative | 45,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001643875-26-000004 · wk-form4_1771626422.xml · derivative · entry 1 Braunstein Scott · CIK 0001643875 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:27 UTC |
GUGGENHIME ANDREWDirector
|
GrantOption to purchase Common Stock · Derivative | 45,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001230724-26-000004 · wk-form4_1771626452.xml · derivative · entry 1 GUGGENHIME ANDREW · CIK 0001230724 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:28 UTC |
Whiting NancyDirector
|
GrantOption to purchase Common Stock · Derivative | 45,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001880609-26-000002 · wk-form4_1771626490.xml · derivative · entry 1 Whiting Nancy · CIK 0001880609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:27 UTC |
Richardson-Heron DaraDirector
|
GrantOption to purchase Common Stock · Derivative | 45,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001893193-26-000003 · wk-form4_1771626471.xml · derivative · entry 1 Richardson-Heron Dara · CIK 0001893193 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:27 UTC |
JOHNSON DAVID LEEDirector
|
GrantOption to purchase Common Stock · Derivative | 45,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001733883-26-000004 · wk-form4_1771626459.xml · derivative · entry 1 JOHNSON DAVID LEE · CIK 0001733883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:26 UTC |
Ryali SriramChief Financial Officer
|
GrantOption to purchase Common Stock · Derivative | 247,500 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001762893-26-000002 · wk-form4_1771626395.xml · derivative · entry 2 Ryali Sriram · CIK 0001762893 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,500 Underlying: Common Stock · 247,500 shares Expires 2036-02-19 F2 · derivative.exercise_date: 1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:26 UTC |
Ryali SriramChief Financial Officer
|
GrantCommon Stock | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001762893-26-000002 · wk-form4_1771626395.xml · nonDerivative · entry 1 Ryali Sriram · CIK 0001762893 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,360 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 20:53 UTC |
Albertson Tina M.Chief Medical Officer
|
GrantOption to purchase Common Stock · Derivative | 247,500 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001917391-26-000002 · wk-form4_1771984424.xml · derivative · entry 3 Albertson Tina M. · CIK 0001917391 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 247,500 Underlying: Common Stock · 247,500 shares Expires 2036-02-19 F3 · derivative.exercise_date: 1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 20:53 UTC |
Albertson Tina M.Chief Medical Officer
|
GrantCommon Stock | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001917391-26-000002 · wk-form4_1771984424.xml · nonDerivative · entry 1 Albertson Tina M. · CIK 0001917391 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,589 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 20:54 UTC |
MCCLUNG BARBARA GChief Legal Officer
|
GrantOption to purchase Common Stock · Derivative | 202,500 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001231321-26-000002 · wk-form4_1771984473.xml · derivative · entry 3 MCCLUNG BARBARA G · CIK 0001231321 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,500 Underlying: Common Stock · 202,500 shares Expires 2036-02-19 F3 · derivative.exercise_date: 1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 20:54 UTC |
MCCLUNG BARBARA GChief Legal Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001231321-26-000002 · wk-form4_1771984473.xml · nonDerivative · entry 1 MCCLUNG BARBARA G · CIK 0001231321 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,502 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:54 UTC |
Kelly Timothy PChief Technology Officer
|
GrantOption to purchase Common Stock · Derivative | 202,500 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001754067-26-000002 · wk-form4_1771984478.xml · derivative · entry 3 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,500 Underlying: Common Stock · 202,500 shares Expires 2036-02-19 F3 · derivative.exercise_date: 1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:54 UTC |
Kelly Timothy PChief Technology Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001754067-26-000002 · wk-form4_1771984478.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,500 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:54 UTC |
Khan Ruhi AhmadChief Business Officer
|
GrantOption to purchase Common Stock · Derivative | 202,500 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001891113-26-000002 · wk-form4_1771984441.xml · derivative · entry 3 Khan Ruhi Ahmad · CIK 0001891113 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,500 Underlying: Common Stock · 202,500 shares Expires 2036-02-19 F3 · derivative.exercise_date: 1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:54 UTC |
Khan Ruhi AhmadChief Business Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001891113-26-000002 · wk-form4_1771984441.xml · nonDerivative · entry 1 Khan Ruhi Ahmad · CIK 0001891113 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,936 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 08:01 UTC |
Haurwitz Rachel E.Director · President and CEO
|
PurchaseCommon Stock | 20,000 | $1.02 | $20,400.00 |
DisclosureSEC source: 0001670579-25-000008 · wk-form4_1742212876.xml · nonDerivative · entry 2 Haurwitz Rachel E. · CIK 0001670579 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 3,369,395 F1 · price: This transaction was executed in multiple trades on 3/14/2025 at prices ranging from $1.00 to $1.03 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the specified range. F2 · ownership.nature: Shares are held by The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse. Read SEC document |
| February 21, 2025 Filed Feb 21, 2025 20:19 UTC |
MCCLUNG BARBARA GChief Legal Officer
|
SaleCommon Stock | 3,564 | $1.35 | $4,811.40 |
DisclosureSEC source: 0001231321-25-000003 · wk-form4_1740187189.xml · nonDerivative · entry 2 MCCLUNG BARBARA G · CIK 0001231321 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,502 F2 · kind: Reflects the number of shares of common stock that were sold in a "sell to cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F2 · shares: Reflects the number of shares of common stock that were sold in a "sell to cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F3 · price: This transaction was executed in multiple trades on 2/21/2025 at prices ranging from $1.32 to $1.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the specified range. Read SEC document |
| February 21, 2025 Filed Feb 22, 2025 01:19 UTC |
Khan Ruhi AhmadChief Business Officer
|
SaleCommon Stock | 3,564 | $1.35 | $4,811.40 |
DisclosureSEC source: 0001891113-25-000003 · wk-form4_1740187160.xml · nonDerivative · entry 2 Khan Ruhi Ahmad · CIK 0001891113 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,936 F2 · kind: Reflects the number of shares of common stock that were sold in a "sell to cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F2 · shares: Reflects the number of shares of common stock that were sold in a "sell to cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F3 · price: This transaction was executed in multiple trades on 2/21/2025 at prices ranging from $1.32 to $1.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the specified range. Read SEC document |
| February 21, 2025 Filed Feb 22, 2025 01:18 UTC |
Kanner StevenChief Scientific Officer
|
SaleCommon Stock | 3,564 | $1.35 | $4,811.40 |
DisclosureSEC source: 0001871131-25-000003 · wk-form4_1740187088.xml · nonDerivative · entry 2 Kanner Steven · CIK 0001871131 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,556 F3 · kind: Reflects the number of shares of common stock that were sold in a "sell to cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F3 · shares: Reflects the number of shares of common stock that were sold in a "sell to cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs. F4 · price: This transaction was executed in multiple trades on 2/21/2025 at prices ranging from $1.32 to $1.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the specified range. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 20:16 UTC |
Sacks NatalieDirector
|
GrantOption to purchase Common Stock · Derivative | 40,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001683811-25-000003 · wk-form4_1740186979.xml · derivative · entry 1 Sacks Natalie · CIK 0001683811 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,500 Underlying: Common Stock · 40,500 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 20:20 UTC |
Albertson Tina M.Chief Medical Officer
|
GrantOption to purchase Common Stock · Derivative | 66,137 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001917391-25-000003 · wk-form4_1740187228.xml · derivative · entry 2 Albertson Tina M. · CIK 0001917391 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,137 Underlying: Common Stock · 66,137 shares Expires 2035-02-19 F2 · derivative.exercise_date: 25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 20:20 UTC |
Albertson Tina M.Chief Medical Officer
|
GrantCommon Stock | 14,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001917391-25-000003 · wk-form4_1740187228.xml · nonDerivative · entry 1 Albertson Tina M. · CIK 0001917391 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,589 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 20:17 UTC |
Zheng RanDirector
|
GrantOption to purchase Common Stock · Derivative | 40,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001885914-25-000003 · wk-form4_1740187054.xml · derivative · entry 1 Zheng Ran · CIK 0001885914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,500 Underlying: Common Stock · 40,500 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 20:21 UTC |
Haurwitz Rachel E.Director · President and CEO
|
GrantOption to purchase Common Stock · Derivative | 618,250 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001670579-25-000003 · wk-form4_1740187261.xml · derivative · entry 3 Haurwitz Rachel E. · CIK 0001670579 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 618,250 Underlying: Common Stock · 618,250 shares Expires 2035-02-19 F3 · derivative.exercise_date: 25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 20:21 UTC |
Haurwitz Rachel E.Director · President and CEO
|
GrantCommon Stock | 136,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001670579-25-000003 · wk-form4_1740187261.xml · nonDerivative · entry 1 Haurwitz Rachel E. · CIK 0001670579 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,450 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:13 UTC |
Braunstein ScottDirector
|
GrantOption to purchase Common Stock · Derivative | 40,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001643875-25-000003 · wk-form4_1740186801.xml · derivative · entry 1 Braunstein Scott · CIK 0001643875 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,500 Underlying: Common Stock · 40,500 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 20:19 UTC |
MCCLUNG BARBARA GChief Legal Officer
|
GrantOption to purchase Common Stock · Derivative | 170,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001231321-25-000003 · wk-form4_1740187189.xml · derivative · entry 3 MCCLUNG BARBARA G · CIK 0001231321 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2035-02-19 F4 · derivative.exercise_date: 25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 20:19 UTC |
MCCLUNG BARBARA GChief Legal Officer
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001231321-25-000003 · wk-form4_1740187189.xml · nonDerivative · entry 1 MCCLUNG BARBARA G · CIK 0001231321 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,066 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:14 UTC |
GUGGENHIME ANDREWDirector
|
GrantOption to purchase Common Stock · Derivative | 40,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001230724-25-000003 · wk-form4_1740186837.xml · derivative · entry 1 GUGGENHIME ANDREW · CIK 0001230724 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,500 Underlying: Common Stock · 40,500 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:18 UTC |
Kelly Timothy PChief Technology Officer
|
GrantOption to purchase Common Stock · Derivative | 170,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001754067-25-000003 · wk-form4_1740187125.xml · derivative · entry 2 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: 25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:18 UTC |
Kelly Timothy PChief Technology Officer
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001754067-25-000003 · wk-form4_1740187125.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:19 UTC |
Khan Ruhi AhmadChief Business Officer
|
GrantOption to purchase Common Stock · Derivative | 170,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001891113-25-000003 · wk-form4_1740187160.xml · derivative · entry 3 Khan Ruhi Ahmad · CIK 0001891113 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2035-02-19 F4 · derivative.exercise_date: 25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:19 UTC |
Khan Ruhi AhmadChief Business Officer
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001891113-25-000003 · wk-form4_1740187160.xml · nonDerivative · entry 1 Khan Ruhi Ahmad · CIK 0001891113 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,500 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:18 UTC |
Kanner StevenChief Scientific Officer
|
GrantOption to purchase Common Stock · Derivative | 170,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001871131-25-000003 · wk-form4_1740187088.xml · derivative · entry 3 Kanner Steven · CIK 0001871131 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2035-02-19 F5 · derivative.exercise_date: 25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:18 UTC |
Kanner StevenChief Scientific Officer
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001871131-25-000003 · wk-form4_1740187088.xml · nonDerivative · entry 1 Kanner Steven · CIK 0001871131 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,120 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. F2 · balance_after: Includes 10,583 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2025. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:17 UTC |
Whiting NancyDirector
|
GrantOption to purchase Common Stock · Derivative | 40,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001880609-25-000003 · wk-form4_1740187018.xml · derivative · entry 1 Whiting Nancy · CIK 0001880609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,500 Underlying: Common Stock · 40,500 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:15 UTC |
Richardson-Heron DaraDirector
|
GrantOption to purchase Common Stock · Derivative | 40,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001893193-25-000004 · wk-form4_1740186934.xml · derivative · entry 1 Richardson-Heron Dara · CIK 0001893193 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,500 Underlying: Common Stock · 40,500 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:14 UTC |
JOHNSON DAVID LEEDirector
|
GrantOption to purchase Common Stock · Derivative | 40,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001733883-25-000003 · wk-form4_1740186872.xml · derivative · entry 1 JOHNSON DAVID LEE · CIK 0001733883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,500 Underlying: Common Stock · 40,500 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:02 UTC |
Ryali SriramChief Financial Officer
|
PurchaseCommon Stock | 17,360 | $1.42 | $24,651.20 |
DisclosureSEC source: 0001762893-25-000009 · wk-form4_1738270924.xml · nonDerivative · entry 1 Ryali Sriram · CIK 0001762893 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,360 Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 22:06 UTC |
Ryali SriramChief Financial Officer
|
GrantOption to purchase Common Stock · Derivative | 300,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001762893-25-000006 · wk-form4_1736546757.xml · derivative · entry 1 Ryali Sriram · CIK 0001762893 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2035-01-09 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 2, 2026, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following January 2, 2026), subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:01 UTC |
Fischesser RyanVP of Finance and Controller
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001871155-24-000005 · wk-form4_1732309285.xml · nonDerivative · entry 1 Fischesser Ryan · CIK 0001871155 · VP of Finance and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,854 F1 · shares: This reflects restricted stock units ("RSUs") that will vest in full on November 20, 2025, subject to the reporting person's continued services to the Issuer through the vesting date. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.